Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients

Area of Science:

• Cardiovascular Pharmacology
• Lipid Metabolism

Background:

• Pleiotropic effects of statins are not fully understood regarding temporal differences among drug members.
• Hypercholesterolemic patients' responses to statins may vary based on drug class and treatment duration.

Purpose of the Study:

• To investigate and compare the short- and intermediate-term pleiotropic effects of atorvastatin versus cerivastatin in hypercholesterolemic patients.
• To determine if temporal differences exist in the pleiotropic actions of different statin medications.

Main Methods:

• Randomized treatment of 35 hypercholesterolemic patients with either atorvastatin or cerivastatin for 3 months.
• Measurements included fasting lipid profiles, thiobarbituric acid reactive substances (TBARS), fibrinolytic parameters, and flow-mediated dilation (FMD) at baseline, 2 weeks, and 3 months.

Main Results:

• Atorvastatin and cerivastatin demonstrated distinct effects on lipid profiles and pleiotropic markers within 2 weeks and 3 months.
• Cerivastatin showed a greater initial increase in flow-mediated dilation (FMD) after 2 weeks, while atorvastatin's effect on FMD increased over 3 months.
• No correlation was found between pleiotropic effects and lipid profile improvements in either treatment group.

Conclusions:

• The degree and time course of pleiotropic effects vary significantly among different statin drugs.
• Findings suggest that statin selection may influence the timing and extent of non-lipid-lowering benefits.